vs

Side-by-side financial comparison of AVITA Medical, Inc. (RCEL) and SOUTHERN FIRST BANCSHARES INC (SFST). Click either name above to swap in a different company.

SOUTHERN FIRST BANCSHARES INC is the larger business by last-quarter revenue ($31.8M vs $17.6M, roughly 1.8× AVITA Medical, Inc.). On growth, SOUTHERN FIRST BANCSHARES INC posted the faster year-over-year revenue change (26.1% vs -4.3%). SOUTHERN FIRST BANCSHARES INC produced more free cash flow last quarter ($29.9M vs $-6.1M). Over the past eight quarters, AVITA Medical, Inc.'s revenue compounded faster (26.0% CAGR vs 22.2%).

Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East...

First Community Bankshares, Inc. is a $2.43 billion bank holding company and the parent company of First Community Bank of Bluefield, Virginia, in the United States. As of 2012 First Community Bank had 45 locations in Virginia, West Virginia, and North Carolina, and two locations operating as Peoples Community Bank in Tennessee. As of April 21, 2023, First Community had $3.6 billion in assets.

RCEL vs SFST — Head-to-Head

Bigger by revenue
SFST
SFST
1.8× larger
SFST
$31.8M
$17.6M
RCEL
Growing faster (revenue YoY)
SFST
SFST
+30.4% gap
SFST
26.1%
-4.3%
RCEL
More free cash flow
SFST
SFST
$36.0M more FCF
SFST
$29.9M
$-6.1M
RCEL
Faster 2-yr revenue CAGR
RCEL
RCEL
Annualised
RCEL
26.0%
22.2%
SFST

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
RCEL
RCEL
SFST
SFST
Revenue
$17.6M
$31.8M
Net Profit
$-11.6M
Gross Margin
81.2%
Operating Margin
-59.1%
40.1%
Net Margin
-66.0%
Revenue YoY
-4.3%
26.1%
Net Profit YoY
-0.3%
EPS (diluted)
$-0.37
$1.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RCEL
RCEL
SFST
SFST
Q4 25
$17.6M
$31.8M
Q3 25
$17.1M
$31.1M
Q2 25
$18.4M
$28.6M
Q1 25
$18.5M
$26.5M
Q4 24
$18.4M
$25.2M
Q3 24
$19.5M
$23.8M
Q2 24
$15.2M
$23.1M
Q1 24
$11.1M
$21.3M
Net Profit
RCEL
RCEL
SFST
SFST
Q4 25
$-11.6M
Q3 25
$-13.2M
$8.7M
Q2 25
$-9.9M
$6.6M
Q1 25
$-13.9M
$5.3M
Q4 24
$-11.6M
Q3 24
$-16.2M
$4.4M
Q2 24
$-15.4M
$3.0M
Q1 24
$-18.7M
$2.5M
Gross Margin
RCEL
RCEL
SFST
SFST
Q4 25
81.2%
Q3 25
81.3%
Q2 25
81.2%
Q1 25
84.7%
Q4 24
87.6%
Q3 24
83.7%
Q2 24
86.1%
Q1 24
86.4%
Operating Margin
RCEL
RCEL
SFST
SFST
Q4 25
-59.1%
40.1%
Q3 25
-53.6%
36.4%
Q2 25
-60.5%
30.0%
Q1 25
-63.9%
26.1%
Q4 24
-54.1%
27.3%
Q3 24
-70.6%
24.1%
Q2 24
-102.8%
17.0%
Q1 24
-155.0%
15.9%
Net Margin
RCEL
RCEL
SFST
SFST
Q4 25
-66.0%
Q3 25
-77.3%
27.8%
Q2 25
-53.9%
23.0%
Q1 25
-74.9%
19.9%
Q4 24
-63.0%
Q3 24
-82.9%
18.4%
Q2 24
-101.3%
13.0%
Q1 24
-168.0%
11.8%
EPS (diluted)
RCEL
RCEL
SFST
SFST
Q4 25
$-0.37
$1.19
Q3 25
$-0.46
$1.07
Q2 25
$-0.38
$0.81
Q1 25
$-0.53
$0.65
Q4 24
$-0.44
$0.69
Q3 24
$-0.62
$0.54
Q2 24
$-0.60
$0.37
Q1 24
$-0.73
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RCEL
RCEL
SFST
SFST
Cash + ST InvestmentsLiquidity on hand
$18.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$-16.6M
$368.7M
Total Assets
$56.4M
$4.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RCEL
RCEL
SFST
SFST
Q4 25
$18.2M
Q3 25
$23.3M
Q2 25
$15.7M
Q1 25
$25.8M
Q4 24
$35.9M
Q3 24
$44.4M
Q2 24
$54.1M
Q1 24
$68.2M
Stockholders' Equity
RCEL
RCEL
SFST
SFST
Q4 25
$-16.6M
$368.7M
Q3 25
$-6.7M
$356.3M
Q2 25
$-12.9M
$345.5M
Q1 25
$-4.6M
$337.6M
Q4 24
$4.5M
$330.4M
Q3 24
$12.2M
$326.5M
Q2 24
$23.9M
$318.7M
Q1 24
$32.6M
$315.3M
Total Assets
RCEL
RCEL
SFST
SFST
Q4 25
$56.4M
$4.4B
Q3 25
$63.7M
$4.4B
Q2 25
$58.1M
$4.3B
Q1 25
$69.6M
$4.3B
Q4 24
$79.7M
$4.1B
Q3 24
$81.1M
$4.2B
Q2 24
$87.8M
$4.1B
Q1 24
$97.4M
$4.1B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RCEL
RCEL
SFST
SFST
Operating Cash FlowLast quarter
$-5.4M
$30.5M
Free Cash FlowOCF − Capex
$-6.1M
$29.9M
FCF MarginFCF / Revenue
-34.7%
93.8%
Capex IntensityCapex / Revenue
3.8%
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-33.5M
$62.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RCEL
RCEL
SFST
SFST
Q4 25
$-5.4M
$30.5M
Q3 25
$-5.2M
$14.5M
Q2 25
$-10.2M
$10.5M
Q1 25
$-10.3M
$7.6M
Q4 24
$-8.1M
$25.6M
Q3 24
$-7.2M
$26.3M
Q2 24
$-12.8M
$4.0M
Q1 24
$-20.9M
$-2.9M
Free Cash Flow
RCEL
RCEL
SFST
SFST
Q4 25
$-6.1M
$29.9M
Q3 25
$-6.2M
$14.4M
Q2 25
$-10.8M
$10.4M
Q1 25
$-10.5M
$7.4M
Q4 24
$-9.7M
$24.8M
Q3 24
$-11.0M
$26.1M
Q2 24
$-15.4M
$3.9M
Q1 24
$-22.0M
$-3.2M
FCF Margin
RCEL
RCEL
SFST
SFST
Q4 25
-34.7%
93.8%
Q3 25
-36.1%
46.3%
Q2 25
-58.4%
36.3%
Q1 25
-56.9%
28.1%
Q4 24
-52.7%
98.2%
Q3 24
-56.1%
110.0%
Q2 24
-101.6%
16.8%
Q1 24
-198.2%
-15.0%
Capex Intensity
RCEL
RCEL
SFST
SFST
Q4 25
3.8%
1.8%
Q3 25
5.5%
0.3%
Q2 25
2.8%
0.3%
Q1 25
1.2%
0.5%
Q4 24
8.8%
3.1%
Q3 24
19.2%
0.8%
Q2 24
17.5%
0.4%
Q1 24
10.3%
1.3%
Cash Conversion
RCEL
RCEL
SFST
SFST
Q4 25
Q3 25
1.67×
Q2 25
1.59×
Q1 25
1.44×
Q4 24
Q3 24
6.01×
Q2 24
1.32×
Q1 24
-1.16×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons